Literature DB >> 20659747

Tissue-derived proinflammatory effect of adenosine A2B receptor in lung ischemia-reperfusion injury.

Farshad Anvari1, Ashish K Sharma, Lucas G Fernandez, Tjasa Hranjec, Katya Ravid, Irving L Kron, Victor E Laubach.   

Abstract

OBJECTIVE: Ischemia-reperfusion injury after lung transplantation remains a major source of morbidity and mortality. Adenosine receptors have been implicated in both pro- and anti-inflammatory roles in ischemia-reperfusion injury. This study tests the hypothesis that the adenosine A(2B) receptor exacerbates the proinflammatory response to lung ischemia-reperfusion injury.
METHODS: An in vivo left lung hilar clamp model of ischemia-reperfusion was used in wild-type C57BL6 and adenosine A(2B) receptor knockout mice, and in chimeras created by bone marrow transplantation between wild-type and adenosine A(2B) receptor knockout mice. Mice underwent sham surgery or lung ischemia-reperfusion (1 hour ischemia and 2 hours reperfusion). At the end of reperfusion, lung function was assessed using an isolated buffer-perfused lung system. Lung inflammation was assessed by measuring proinflammatory cytokine levels in bronchoalveolar lavage fluid, and neutrophil infiltration was assessed via myeloperoxidase levels in lung tissue.
RESULTS: Compared with wild-type mice, lungs of adenosine A(2B) receptor knockout mice were significantly protected after ischemia-reperfusion, as evidenced by significantly reduced pulmonary artery pressure, increased lung compliance, decreased myeloperoxidase, and reduced proinflammatory cytokine levels (tumor necrosis factor-α; interleukin-6; keratinocyte chemoattractant; regulated on activation, normal T-cell expressed and secreted; and monocyte chemotactic protein-1). Adenosine A(2B) receptor knockout → adenosine A(2B) receptor knockout (donor → recipient) and wild-type → adenosine A(2B) receptor knockout, but not adenosine A(2B) receptor knockout → wild-type, chimeras showed significantly improved lung function after ischemia-reperfusion.
CONCLUSIONS: These results suggest that the adenosine A(2B) receptor plays an important role in mediating lung inflammation after ischemia-reperfusion by stimulating cytokine production and neutrophil chemotaxis. The proinflammatory effects of adenosine A(2B) receptor seem to be derived by adenosine A(2B) receptor activation primarily on resident pulmonary cells and not bone marrow-derived cells. Adenosine A(2B) receptor may provide a therapeutic target for prevention of ischemia-reperfusion-related graft dysfunction in lung transplant recipients.
Copyright © 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659747      PMCID: PMC2943004          DOI: 10.1016/j.jtcvs.2010.06.051

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  30 in total

1.  Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response.

Authors:  S M Fiser; C G Tribble; S M Long; A K Kaza; J T Cope; V E Laubach; J A Kern; I L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2001-06       Impact factor: 5.209

2.  Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosine.

Authors:  M W Beukers; H den Dulk; E W van Tilburg; J Brouwer; A P Ijzerman
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

3.  Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.

Authors:  Laura M Kreckler; Tina C Wan; Zhi-Dong Ge; John A Auchampach
Journal:  J Pharmacol Exp Ther       Date:  2005-12-09       Impact factor: 4.030

4.  Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation.

Authors:  S D Ross; C G Tribble; J R Gaughen; K S Shockey; P E Parrino; I L Kron
Journal:  Ann Thorac Surg       Date:  1999-05       Impact factor: 4.330

5.  The A2B adenosine receptor protects against inflammation and excessive vascular adhesion.

Authors:  Dan Yang; Ying Zhang; Hao G Nguyen; Milka Koupenova; Anil K Chauhan; Maria Makitalo; Matthew R Jones; Cynthia St Hilaire; David C Seldin; Paul Toselli; Edward Lamperti; Barbara M Schreiber; Haralambos Gavras; Denisa D Wagner; Katya Ravid
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

6.  Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury.

Authors:  Minqing Zhao; Lucas G Fernandez; Allan Doctor; Ashish K Sharma; Alexander Zarbock; Curtis G Tribble; Irving L Kron; Victor E Laubach
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-07-21       Impact factor: 5.464

7.  Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells.

Authors:  P Huang; E R Lazarowski; R Tarran; S L Milgram; R C Boucher; M J Stutts
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

8.  Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury.

Authors:  Chun-Xiao Sun; Hongyan Zhong; Amir Mohsenin; Eva Morschl; Janci L Chunn; Jose G Molina; Luiz Belardinelli; Dewan Zeng; Michael R Blackburn
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

9.  A(2B) adenosine receptors increase cytokine release by bronchial smooth muscle cells.

Authors:  Hongyan Zhong; Luiz Belardinelli; Tenning Maa; Igor Feoktistov; Italo Biaggioni; Dewan Zeng
Journal:  Am J Respir Cell Mol Biol       Date:  2003-07-10       Impact factor: 6.914

10.  Synergy between A2B adenosine receptors and hypoxia in activating human lung fibroblasts.

Authors:  Hongyan Zhong; Luiz Belardinelli; Tenning Maa; Dewan Zeng
Journal:  Am J Respir Cell Mol Biol       Date:  2004-10-07       Impact factor: 6.914

View more
  18 in total

Review 1.  Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.

Authors:  Vibha N Lama; John A Belperio; Jason D Christie; Souheil El-Chemaly; Michael C Fishbein; Andrew E Gelman; Wayne W Hancock; Shaf Keshavjee; Daniel Kreisel; Victor E Laubach; Mark R Looney; John F McDyer; Thalachallour Mohanakumar; Rebecca A Shilling; Angela Panoskaltsis-Mortari; David S Wilkes; Jerry P Eu; Mark R Nicolls
Journal:  JCI Insight       Date:  2017-05-04

Review 2.  The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases.

Authors:  Anna Eisenstein; Shenia Patterson; Katya Ravid
Journal:  J Cell Physiol       Date:  2015-12       Impact factor: 6.384

3.  Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury.

Authors:  Daniel P Mulloy; Ashish K Sharma; Lucas G Fernandez; Yunge Zhao; Christine L Lau; Irving L Kron; Victor E Laubach
Journal:  Ann Thorac Surg       Date:  2013-03-28       Impact factor: 4.330

4.  NOX2 Activation of Natural Killer T Cells Is Blocked by the Adenosine A2A Receptor to Inhibit Lung Ischemia-Reperfusion Injury.

Authors:  Ashish K Sharma; Damien J LaPar; Matthew L Stone; Yunge Zhao; Christopher K Mehta; Irving L Kron; Victor E Laubach
Journal:  Am J Respir Crit Care Med       Date:  2016-05-01       Impact factor: 21.405

5.  Attenuation of Pulmonary Ischemia-Reperfusion Injury by Adenosine A2B Receptor Antagonism.

Authors:  Mary E Huerter; Ashish K Sharma; Yunge Zhao; Eric J Charles; Irving L Kron; Victor E Laubach
Journal:  Ann Thorac Surg       Date:  2016-04-22       Impact factor: 4.330

6.  Lungs donated after circulatory death and prolonged warm ischemia are transplanted successfully after enhanced ex vivo lung perfusion using adenosine A2B receptor antagonism.

Authors:  Eric J Charles; J Hunter Mehaffey; Ashish K Sharma; Yunge Zhao; Mark H Stoler; James M Isbell; Christine L Lau; Curtis G Tribble; Victor E Laubach; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2017-04-12       Impact factor: 5.209

Review 7.  Extracellular nucleotide signaling in solid organ transplantation.

Authors:  Scott Yeudall; Norbert Leitinger; Victor E Laubach
Journal:  Am J Transplant       Date:  2019-11-04       Impact factor: 8.086

8.  Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysms.

Authors:  Castigliano M Bhamidipati; Gaurav S Mehta; Christopher W Moehle; Akshaya K Meher; Gang Su; Navin G Vigneshwar; Carlos Barbery; Ashish K Sharma; Irving L Kron; Victor E Laubach; Gary K Owens; Gilbert R Upchurch; Gorav Ailawadi
Journal:  FASEB J       Date:  2013-02-14       Impact factor: 5.191

9.  Adenosine A(2B) receptor deficiency promotes host defenses against gram-negative bacterial pneumonia.

Authors:  Kathryn E Barletta; R Elaine Cagnina; Marie D Burdick; Joel Linden; Borna Mehrad
Journal:  Am J Respir Crit Care Med       Date:  2012-09-20       Impact factor: 21.405

Review 10.  Targeting of adenosine receptors in ischemia-reperfusion injury.

Authors:  Victor E Laubach; Brent A French; Mark D Okusa
Journal:  Expert Opin Ther Targets       Date:  2010-11-29       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.